Clincosm LogoSign in Get a demo

refractory ovarian carcinoma

Showing 1 - 10 of 10
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Advanced Biliary Tract Carcinoma, Advanced Colorectal Carcinoma, Advanced Gastroesophageal Junction Adenocarcinoma Trial in

Not yet recruiting
  • Advanced Biliary Tract Carcinoma
  • +32 more
  • Biospecimen Collection
  • +6 more
  • Chicago, Illinois
    Northwestern University
Feb 6, 2023

Platinum-Resistant Fallopian Tube Carcinoma, Platinum-Resistant Ovarian Carcinoma, Platinum-Resistant Primary Peritoneal

Completed
Has Results
  • Platinum-Resistant Fallopian Tube Carcinoma
  • +8 more
  • Bevacizumab
  • Irinotecan Sucrosofate
  • Chicago, Illinois
    Northwestern University
Dec 21, 2022

Malignant Abdominal Tumor, Malignant Pelvic Tumor, Recurrent Colon Carcinoma Trial in Rochester (Cisplatin, Cytoreductive

Recruiting
  • Malignant Abdominal Neoplasm
  • +26 more
  • Rochester, Minnesota
    Mayo Clinic in Rochester
Jan 5, 2023

Advanced Malignant Solid Tumor, Refractory Malignant Solid Tumor, Refractory Ovarian Carcinoma Trial in Houston (TRPV6 Calcium

Recruiting
  • Advanced Malignant Solid Neoplasm
  • +22 more
  • TRPV6 Calcium Channel Inhibitor SOR-C13
  • Houston, Texas
    M D Anderson Cancer Center
Oct 20, 2022

Metastatic Malignant Solid Tumor, Recurrent Malignant Solid Tumor, Recurrent Platinum-Resistant Ovarian Carcinoma Trial in

Recruiting
  • Metastatic Malignant Solid Neoplasm
  • +3 more
  • BET Bromodomain Inhibitor ZEN-3694
  • +2 more
  • Bethesda, Maryland
  • +4 more
Aug 16, 2022

Platinum-Resistant Fallopian Tube Carcinoma, Platinum-Resistant Ovarian Carcinoma, Platinum-Resistant Primary Peritoneal

Recruiting
  • Platinum-Resistant Fallopian Tube Carcinoma
  • +8 more
  • Durvalumab
  • Tremelimumab
  • Houston, Texas
    M D Anderson Cancer Center
Jul 19, 2022

Platinum-Resistant Fallopian Tube Carcinoma, Platinum-Resistant Ovarian Carcinoma, Platinum-Resistant Primary Peritoneal

Active, not recruiting
  • Platinum-Resistant Fallopian Tube Carcinoma
  • +11 more
  • Aldesleukin
  • +3 more
  • Buffalo, New York
    Roswell Park Cancer Institute
Jul 13, 2022

Anatomic Stage III Breast Cancer AJCC v8, Anatomic Stage IV Breast Cancer AJCC v8, Locally Advanced Breast Carcinoma Trial in

Not yet recruiting
  • Anatomic Stage III Breast Cancer AJCC v8
  • +14 more
  • Biopsy
  • +25 more
  • Portland, Oregon
    OHSU Knight Cancer Institute
Jul 12, 2022

Malignant Ovarian Epithelial Tumor, Platinum-Resistant Fallopian Tube Carcinoma, Platinum-Resistant Ovarian Carcinoma Trial in

Recruiting
  • Malignant Ovarian Epithelial Tumor
  • +9 more
  • Akt/ERK Inhibitor ONC201
  • +2 more
  • Detroit, Michigan
    Barbara Ann Karmanos Cancer Institute
May 10, 2022

Advanced Malignant Solid Tumor, KRAS Gene Mutation, Ovarian Carcinoma Trial in Houston (Paclitaxel, Pharmacokinetic Study,

Active, not recruiting
  • Advanced Malignant Solid Neoplasm
  • +4 more
  • Houston, Texas
    M D Anderson Cancer Center
Dec 13, 2021